Effects of baru oil or mineral oil supplementation on the bowelfunction of hemodialysis patients
Not Applicable
- Conditions
- Kidney failure chronic, renal dialysis, constipation.C12.777.419.780.750.500E02.870.300C23.888.821.150
- Registration Number
- RBR-3hj4ny
- Lead Sponsor
- niversidade Federal de Goiás
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Chronic renal patients in an adequate hemodialysis treatment (Kt / V greater than 1.2), via arteriovenous fistula, of both sexes, aged between 25 and 70 years and who did not use laxative.
Exclusion Criteria
Patients with a history of acute myocardial infarction in the last six months; recent hospitalization (less than three months from the start of the study), decompensated diabetes, presence of thyroid dysfunction, patients with acute infections and patients who presented food intolerance to baru or allergy to any oilseed.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The present study is expected to reduce the frequency of patients classified as constipated, as verified by the criterion Rome IV, based on a reduction of at least 5% in this frequency.
- Secondary Outcome Measures
Name Time Method A stool consistency reduction, as measured by the Bristol scale, is expected to be reduced by two ordinal points in stool consistency.;The improvement in constipation, reported in the primary outcome, is expected to modify body composition by reducing the percentage of fat, evaluated by the four-way electric bioimpedance method, with a reduction of approximately 5 percentage points of body fat.